EPIPEN Act

This bill requires most health insurance plans (both group and individual) to cover FDA-approved epinephrine auto-injectors without applying deductibles. It caps out-of-pocket costs at $60 per package of two injectors, and any payments toward this limit count toward the plan’s annual out-of-pocket maximum. The requirement applies to plans covered under the Public Health Service Act, ERISA, and Internal Revenue Code, effective for plan years beginning January 1, 2025. It directly affects insured individuals needing epinephrine for severe allergic reactions by reducing their immediate financial burden.